New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 20, 2014
07:35 EDTBONEBacterin announces publication of OsteoSponge clinical results
Bacterin announced that results utilizing OsteoSponge bone graft for foot and ankle arthrodeses procedures has been published in the peer-reviewed journal Orthopedics. The article reports a prospective analysis of 25 patients who underwent foot and ankle arthrodesis involving 45 total joints. Results indicated that 96% of patients showed radiographic fusion at 6 and 12 months postoperative assessment, with a 97.4% overall fusion rate. Pain was assessed pre and postoperatively via visual analog scale, with statistically significant improvements at 6 and 12 months relative to preoperative pain scores. Functional outcomes were significantly improved at 6 and 12 months compared with preoperative assessment according to American Orthopaedic Foot and Ankle Society scores.
News For BONE From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 6, 2015
07:33 EDTBONEBacterin announces OsteoSponge patent
Bacterin International Holdings announced that the United States Patent and Trademark Office has issued US Patent No. 8,992,964 entitled "Process for Demineralization of Bone Matrix with Preservation of Natural Growth Factors." The issued claims in the patent cover certain demineralized bone matrixes containing minimum levels of bone morphogenetic protein-2, which include products in Bacterin's OsteoSponge product line. Bacterin has pending continuing applications in the United States to pursue protection on other aspects of its bone demineralization technology.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use